Background {#Sec1}
==========

Osteosarcoma (OS) is an aggressive bone cancer that commonly occurs in children and adolescents accounting for about more than 60% of the malignant bone tumours in patients under the age of 20 years \[[@CR1], [@CR2]\]. OS mainly originates from active regions in the bone, including lower femur, upper tibia, and knee joint \[[@CR3], [@CR4]\]. Common manifestations in patients with OS include the onset of pain and bone swelling, and the pain is strong enough to wake a patient up \[[@CR5]\]. Statistics showed that the improvement of surgical techniques as well as the use of multiple doses and dose-intensive chemotherapy increased the 5-year survival of patients with localized OS to 60%, but this outcome still needs to be improved \[[@CR6]\]. Evidence has proved that patients with OS are at high risk of local invasion and early systemic metastasis \[[@CR7]\]. Besides, traditional OS is accompanied by diverse genomic aberrations and gene expression changes at the molecular level \[[@CR8]\]. Therefore, finding new therapeutic targets and methods has become an important challenge in OS treatment.

Long-non-coding RNAs (lncRNAs) are important regulatory molecules that are involved in diverse biological processes \[[@CR9]\]. Significantly altered expression of lncRNAs is observed in OS tissues and cells \[[@CR10]\]. Anti-differentiation non-coding RNA (ANCR) containing 855 base pairs maintains the undifferentiated state of epidemic stem cells and osteoblast cells \[[@CR11]\]. ANCR expression is usually decreased during the differentiation process. Previous evidence has revealed that ANCR can influence the growth of periodontal ligament stem cells as well as the osteogenic differentiation \[[@CR12]\]. Noteworthy, ANCR is also a key regulator in OS pathogenesis. It has been proved that ANCR knockdown in U2OS cells inhibits both cell viability and colony formation ability \[[@CR13]\]. ANCR knockdown in MG-63 and UMR-106 cells inhibits cell proliferation, migration, and invasion \[[@CR14]\]. P38 mitogen-activated protein kinase (p38MAPK), a kinase present in postsynaptic dendrites, is involved in the regulation of cytoskeletal reorganization \[[@CR15], [@CR16]\]. p38MAPK can be activated by the upstream kinases, MKK3 and MKK6, and activation of p38MAPK regulates cell migration and metastasis \[[@CR17]\]. Interestingly, accumulating evidence has confirmed the important role of the MAPK signalling pathway in OS \[[@CR18], [@CR19]\]. For example, capsaicin inhibits viability and colony formation, and induces the cell cycle arrest at G0/G1 phase in three OS cell lines, MG63, 143B, and HOS through activating the MAPK signalling pathway \[[@CR20]\]. Escin induces the apoptosis and autophagy of HOS and Saos-2 cells by activating the MAPK signalling pathway \[[@CR21]\]. However, whether the regulatory mechanism of ANCR in OS cells is associated with the MAPK signalling pathway remains unclear. Thus, we evaluated the specific effects of lncRNA-ANCR on cell migration and invasion as well as the potential mechanism involving the MAPK signalling pathway in OS cells.

Methods {#Sec2}
=======

Sample collection {#Sec3}
-----------------

A total of 61 patients with OS (35 males and 26 females, aged 14\~54 years, median age 27 years) were screened from the orthopaedics department of our hospital between January 2012 and December 2017. OS and adjacent normal tissues (adjacent mucosa) were collected from patients who underwent surgery. All tumour specimens were pathologically confirmed and preserved in liquid nitrogen within 30 min after surgery. This study was approved by the ethics committee of Jinan Central Hospital Affiliated to Shandong University. Informed consent was obtained from all subjects as well as parental consent for subjects aged less than 18 years.

Cell culture {#Sec4}
------------

OS cell lines, MG-63 (\#TCHu124), SW1353 (\#TCHu128), U2OS (\#TCHu88), and UMR-106 (\#TCR11) as well as the osteoblast cell line, hFOB1.19 (\#GNHu14) were purchased from Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Cells were cultured in Dulbecco's modified Eagle's Medium (DMEM) (HyClone) containing 10% foetal bovine serum (Gibco, Grand Island, NY, USA) in a constant temperature incubator at 37 °C and 5% CO~2~. Cells were passaged at the ratio of 1:3 at 90% confluence.

Quantitative real time PCR (qRT-PCR) {#Sec5}
------------------------------------

Total RNA was extracted from specific tissues and cells using TRIzol total RNA extraction kit. cDNA was synthesised by reverse transcription. qRT-PCR was performed on a ABI7500 PCR instrument (ABI, Austin, TX, USA) using the following conditions: 95 °C for 10 min, 50 cycles of 95 °C for 15 s, 60 °C for 1 min, and 72 °C for 40 s. The primer sequences are shown in Table [1](#Tab1){ref-type="table"}. 18S rRNA was used as an internal control and the 2^-ΔΔCt^ method was used to analyse the data. This experiment was repeated five times. Table 1Primer sequences of RT-PCRPrimer sequencesLncRNA ANCR5′-GACATTTCCTGAGTCGTCTTCGAACGGAC-3′5′-TAGTGCGATTTAGAGCTGTACAAGTTTC-3′18r RNA5′-ACACGGACAGGATTGACAGA-3′5′-GGACATCTAAGGGCATCACA-3′*RT-PCR* Reverse transcription-polymerase chain reaction

Cell grouping {#Sec6}
-------------

Cells were transfected with ANCR siRNA (F: 5′-GATCCCCGAGCTAGAGCAGTGACAATTTCAAGAGAATTGTCACTGCTCTAGCTCTTTTTC-3′; R: 5′-TCGAGAAAAAGAGCTAGAGCAGTGACAATTCTCTTGAAATTGTCACTGCTCTAGCTCGGG-3′) (si-ANCR group) or siRNA negative control (F: 5′-GATCCCCTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAGAATTTTTC-3′; R: 5′-TCGAGAAAAATTCTCCGAACGTGTCACGTTCTCTTGAAACGTGACACGTTCGGAGAAGGG-3′) (NC group) using the Lipofectamine™ 2000 Transfection reagent (Invitrogen, Carlsbad, CA, USA). Cells in the si-ANCR + SB203580 group were transfected with ANCR siRNA and SB203580 (p38MAPK inhibitor SB203580, Merck, NJ, USA; final concentration, 50 μmol/L). Untransfected cells were used as the blank group. Cells were used for further assays at 48 h post-transfection.

Cell counting kit-8 (CCK-8) assay {#Sec7}
---------------------------------

CCK-8 assay was performed using the CCK-8 kit (Beyotime, Shanghai, China) as previously described \[[@CR22]\]. The OD~450~ was determined with a microplate reader (Bio-Rad, Hercules, CA, USA). Six duplicated wells were set for this experiment.

EdU proliferation assay {#Sec8}
-----------------------

Cells were inoculated into 6-well plates (3 × 10^3^ cells/well) and cultured for 24 h. After 30 min of fixation with 4% formaldehyde, and 10 min of treatment with 0.5% Triton X-100 for 10 min, cells were stained with EdU (red) for 1 h, and counter-stained with Hoechst33342 (blue) for 30 min. The percentage of EdU positive staining was considered as the cell proliferation rate. Three duplicated wells were set for this experiment.

Transwell assay {#Sec9}
---------------

Transwell assay was performed by using a Transwell chamber (BD, USA) as previously described \[[@CR23]\]. Cells passing into the lower chamber were counted in the upper, low, left, right, and middle fields of vision under a microscope (Olympus, Japan).

Western blot analysis {#Sec10}
---------------------

Total proteins were isolated from cells, separated by 10% SDS-polyacrylamide gel electrophoresis and transferred into a Polyvinylidene Fluoride (PVDF) membrane (Millipore, Billerica, MA, USA). After 1 h of blocking with 0.5% dried skimmed milk at 25 °C, the membrane was incubated with the primary antibody at 4 °C overnight. The primary antibodies included antibodies against p38MAPK (ab32142, 1:100), p-p38MAPK (ab47363, 1:100), E-cadherin (ab1416, 1:50), N-cadherin (ab18203, 1:300), and GAPDH (ab9385, 1:5000). Subsequently, the membrane was incubated with sheep anti-rabbit second antibody for 1 h. Protein bands were developed with a chemiluminescent reagent, transformed to grey and quantified using an imaging software. The relative expression of the target protein was standardized with respect to GAPDH that was used as an internal reference (grey value).

Statistical analysis {#Sec11}
--------------------

Data were processed with SPSS 21.0. Data normality was analysed by the Kolmogorov-Smirnov test. The data were expressed as mean ± standard deviation. Student *t* test was conducted to compare two groups. Single factor analysis of variance (ANOVA) was conducted to compare multiple groups. The non-parametric Kruskal-Wallis test was used to analyse the skewness of data, and Dunn's test of multiple comparisons was performed. *P* \< 0.05 represented statistically significant.

Results {#Sec12}
=======

ANCR is up-regulated in OS {#Sec13}
--------------------------

ANCR expression in OS tissues was significantly higher than that in adjacent normal tissues (adjacent mucosa) (Fig. [1](#Fig1){ref-type="fig"}a). Significantly higher ANCR expression was observed in OS cell lines (MG-63, SW1353, U2OS, and UMR-106) than that in hFoB1.19 cells (*P* \< 0.05) (Fig. [1](#Fig1){ref-type="fig"}b). Among the four OS cell lines, MG-63 cells (relatively high ANCR expression) and U2OS cells (relatively low ANCR expression) were used for further assays. ANCR expression was significantly down-regulated in both MG-63 and U2OS cells at 48 h of si-ANCR transfection (*P* \< 0.05). The transfection of NC in MG-63 and U2OS cells did not influence ANCR expression (Fig. [1](#Fig1){ref-type="fig"}c and d). Fig. 1The expression of lncRNA-ANCR in osteosarcoma (OS) tissues and cells detected by quantitative real time PCR. **a** relative expression of ANCR in OS tissue and adjacent normal tissues (adjacent mucosa) at the mRNA level (*N* = 61); **b** relative expression of ANCR in four OS cell lines, including MG-63, SW1353, U2OS and UMR-106, as well as osteoblast cell line hFOB1.19 at the mRNA level (*N* = 5); **c** relative expression of ANCR in transfected MG-63 cells at the mRNA level (*N* = 5); **d** relative expression of ANCR in transfected U2OS cells at the mRNA level (*N* = 5). si-ANCR, cells transfected with siRNA-ANCR for 48 h; NC, cells transfected with siRNA negative control for 48 h; Blank, cells without transfection. \*, *P* \< 0.05 vs. adjacent mucosa (**a**), hFOB1.19 cells (**b**), as well as NC and Blank (**c** and **d**)

Silencing of ANCR inhibits the proliferation of OS cells {#Sec14}
--------------------------------------------------------

The CCK-8 assay was used to determine the viability of MG-63 and U2OS cells. The OD~450nm~ was significantly increased in both MG-63 and U2OS cells in a time- and dose-dependent manner. After 48 and 72 h of culturing, the si-ANCR group exhibited significantly lower OD than the blank and NC groups (*P* \< 0.05) (Fig. [2](#Fig2){ref-type="fig"}a and b). Compared with the blank and NC groups, the proliferation rate in the si-ANCR group was significantly decreased, as seen the by EdU assay (Fig. [2](#Fig2){ref-type="fig"}c and d). No significant differences were observed between blank and NC groups with respect to the OD and proliferation rate (Fig. [2](#Fig2){ref-type="fig"}a-d). The above findings indicate that silencing of ANCR can inhibit the proliferation of OS cells. Fig. 2The proliferation of MG-63 and U2OS cells. **a** OD (450) values of MG-63 cells detected by CCK-8 assay (*N* = 6); **b** OD (450) values of U2OS detected by CCK-8 assay (*N* = 6); **c** the proliferation rat (%) of transfected MG-63 cells detected by EdU assay (*N* = 3); **d** the proliferation rat (%) of transfected U2OS cells detected by EdU assay (*N* = 3). si-ANCR, cells transfected with siRNA-ANCR for 48 h; NC, cells transfected with siRNA negative control for 48 h; Blank, cells without transfection. \*, *P* \< 0.05 vs. NC; \#, *P* \< 0.05 vs. Blank

Silencing of ANCR suppresses the migration and invasion of OS cells {#Sec15}
-------------------------------------------------------------------

The Transwell assay was used to determine cell migration and invasion in the different cell groups. The percentages of cell migration (Fig. [3](#Fig3){ref-type="fig"}a and b) and invasion (Fig. [3](#Fig3){ref-type="fig"}c and d) were significantly lower in the si-ANCR group than that in the blank and NC groups. The levels of cell migration and invasion-related proteins were further determined by western blot. The si-ANCR group showed up-regulated E-cadherin and down-regulated N-cadherin at the protein level relative to the blank and NC groups (*P* \< 0.05) (Fig. [3](#Fig3){ref-type="fig"}e and f). The migration and invasion were not significantly influenced by NC transfection in MG-63 and U2OS cells (Fig. [3](#Fig3){ref-type="fig"}a-f). The above findings indicate that ANCR silencing can suppress the migration and invasion of OS cells. Fig. 3The migration and invasion of MG-63 and U2OS cells detected by Transwell assay and Western blot. **a** the percentage of migratory MG-63 cells (%) (*N* = 3); **b** the percentage of migratory U2OS cells (%) (*N* = 3); **c** the percentage of invasive MG-63 cells (%) (*N* = 3); **d** the percentage of invasive U2OS cells (%) (*N* = 3); **e** the expression of E-cadherin and N-cadherin in MG-63 cells at the protein level (*N* = 3); **f** the expression of E-cadherin and N-cadherin in U2OS cells at the protein level (*N* = 3). si-ANCR, cells transfected with siRNA-ANCR for 48 h; NC, cells transfected with siRNA negative control for 48 h; Blank, cells without transfection. \*, *P* \< 0.05 vs. NC; \#, *P* \< 0.05 vs. Blank

ANCR silencing activated the p38MAPK signalling pathway in OS cells {#Sec16}
-------------------------------------------------------------------

The expression of the p-p38MAPK protein in the si-ANCR group was significantly higher than that in the blank and NC groups (*P* \< 0.05), while the expression of the p38MAPK protein was not significantly changed (Fig. [4](#Fig4){ref-type="fig"}a and b). In addition, no significant differences were observed between the blank and NC groups with respect to the expression of p-p38MAPK and p38MAPK (Fig. [4](#Fig4){ref-type="fig"}a and b). The above findings indicate that ANCR silencing may influence the biological function of OS cells by activating the p38MAPK signalling pathway. Fig. 4The expression of p38MAPK, and phosphorylated p38MAPK (p-p38MAPK) in MG-63 and U2OS cells detected by Western blot. **a** relative expression of p38MAPK and p-p38MAPK in MG-63 cells at the protein level (*N* = 3); **b** relative expression of p38MAPK and p-p38MAPK in U2OS cells at the protein level (*N* = 3). si-ANCR, cells transfected with siRNA-ANCR for 48 h; NC, cells transfected with siRNA negative control for 48 h; Blank, cells without transfection. \*, *P* \< 0.05 vs. NC; \#, *P* \< 0.05 vs. Blank

Inhibition of the p38MAPK signalling pathway eliminated the inhibitory effects of si-ANCR on the migration and invasion of OS cells {#Sec17}
-----------------------------------------------------------------------------------------------------------------------------------

In order to identify whether the effects of ANCR on cell migration and invasion are associated with MAPK signalling, SB203580 was used to inhibit the MAPK signalling pathway in MG-63 and U2OS cells. The Transwell assay showed that the percentage of cell migration was significantly increased upon treatment with SB203580 in both NC and si-ANCR groups (*P* \< 0.05) (Fig. [5](#Fig5){ref-type="fig"}a and b). The percentage of invasive cells in NC and si-ANCR groups was also significantly increased upon treatment with SB203580 (*P* \< 0.05) (Fig. [5](#Fig5){ref-type="fig"}c and d). The expression of migration and invasion-related proteins was further determined by western blot. SB203580 significantly down-regulated E-cadherin and up-regulated N-cadherin at the protein level (*P* \< 0.05) (Fig. [5](#Fig5){ref-type="fig"}e and f). The above findings suggest that the inhibition of the p38MAPK signalling in OS cells can reduce si-ANCR-induced inhibition of cell migration and invasion. Fig. 5The migration and invasion of MG-63 and U2OS cells under the intervention of SB203580 (p38MAPK inhibitor) detected by Transwell assay and Western blot. **a** the percentage of migratory MG-63 cells (%) (*N* = 3); **b** the percentage of migratory U2OS cells (%) (*N* = 3); **c** the percentage of invasive MG-63 cells (%) (*N* = 3); **d** the percentage of invasive U2OS cells (%) (*N* = 3); **e** the expression of E-cadherin and N-cadherin in MG-63 cells at the protein level (*N* = 3); **f** the expression of E-cadherin and N-cadherin in U2OS cells at the protein level (*N* = 3). si-ANCR, cells transfected with siRNA-ANCR for 48 h; si-ANCR + SB203580, cells transfected with siRNA-ANCR and SB203580 (50 μmol/L) for 48 h; NC, cells transfected with siRNA negative control for 48 h; NC + SB203580, cells transfected with siRNA negative control and SB203580 (50 μmol/L) for 48 h. \*, *P* \< 0.05 vs. NC; \#, *P* \< 0.05 vs. si-ANCR + SB203580

Discussion {#Sec18}
==========

OS is a bone sarcoma associated with a high level of genomic instability and high propensity for metastasis \[[@CR24]\]. Many studies have shown that lncRNAs play a key regulatory role in cell proliferation, differentiation, senescence, and carcinogenesis \[[@CR25]--[@CR27]\]. Evidence has shown that cancer-associated lncRNAs exhibit carcinogenic or inhibitory effects on cancers, and that these lncRNAs may also be used as potential biomarkers or therapeutic targets \[[@CR28], [@CR29]\]. Therefore, we chose lncRNA-ANCR as the research focus of this study, and analysed the regulatory effect of ANCR in OS as well as the mechanism involving MAPK signalling pathway. Our results showed that ANCR silencing in OS cells could suppress cell proliferation, migration, and invasion via activating the p38MAPK signalling pathway.

In our research, ANCR expression was determined in OS cells and tissues, and a relatively high ANCR expression was observed. This finding is consistent with a previous study showing that ANCR expression is increased in OS tissues and cells \[[@CR14]\]. Then, ANCR was down-regulated in OC cells through 48 h of transfection with si-ANCR and the cell biological processes were analysed. We found that ANCR silencing inhibited cell proliferation, migration and invasion, up-regulated E-cadherin, and down-regulated N-cadherin in MG-63 and U2OS cells. Although the prognosis of patients with OS improved significantly with chemotherapy, a proportion of those patients do not respond well to chemotherapeutic drugs. In addition, distant metastasis and local recurrence following surgical resection and chemotherapy also lead to poor prognosis \[[@CR30]\]. The transmembrane glycoprotein E-cadherin plays an important role in homophilic cell interactions. Loss of E-cadherin function may promote tumour progression through inducing motile and invasive phenotypes \[[@CR31], [@CR32]\]. The adhesion protein N-cadherin is involved in the regulation of bone formation and embryonic development \[[@CR33]\]. Previous research has proved that E-cadherin and N-cadherin are key regulatory molecules in cell adhesion, migration as well as tumour invasiveness \[[@CR34]\]. In agreement with our study, Zhang et al. have proved that cell proliferation, migration, and invasion were suppressed by ANCR silencing in OS cells \[[@CR14]\].

The MAPK family exerts a key regulatory role in the OS cell survival and angiogenesis \[[@CR35]\]. Here, the effect of ANCR silencing on the biological function of OS cells was found to be associated with the activation of the p38MAPK signalling. The si-ANCR-induced anti-metastasis effect was eliminated by blocking p38MAPK. It was previously reported that the increase in p38MAPK levels inhibits the formation of metastatic tumours \[[@CR36]\]. In addition, p38MAPK positively regulated the expression of E-cadherin, Snail, and Slug proteins \[[@CR37], [@CR38]\]. Another study suggested that the inhibition of the MAPK pathway can induce EZH2 expression in human breast cancer cells \[[@CR39]\]. Furthermore, silencing of lncRNA-ANCR down-regulated EZH2 in OS at the mRNA level of \[[@CR14]\]. Therefore, we speculate that ANCR silencing may influence the function of OS cells by activating the p38MAPK signalling pathway.

Conclusions {#Sec19}
===========

As a conclusion, lncRNA-ANCR was up-regulated in OS. Silencing of lncRNA-ANCR suppressed cell proliferation, migration, and invasion through activation of the p38MAPK signalling pathway, which has an important clinical significance in the treatment of OS.

lncRNA

:   Long non-coding RNA

NC

:   Negative control

OS

:   Osteosarcoma
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